Metabolic tumor volume, cancer cell fraction, and prognosis – the case of T-cell/histiocyte-rich large B-cell lymphoma

Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial

(2019) Andreas Hüttmann et al.   ANNALS OF HEMATOLOGY

Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial

(2019) Christine Schmitz et al.   EUROPEAN JOURNAL OF CANCER

T cell/histiocyte-rich large B cell lymphoma: incidence, demographic disparities, and long-term outcomes

(2018) Anuhya Kommalapati et al.   BRITISH JOURNAL OF HAEMATOLOGY

Combination of baseline FDG PET/CT total metabolic tumour volume and gene expression profile have a robust predictive value in patients with diffuse large B-cell lymphoma

(2018) Mathieu Nessim Toledano et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Positron Emission Tomography–Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial

(2018) Ulrich Dührsen et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

(2018) Bjoern Chapuy et al.   NATURE MEDICINE

Prognostic significance of total metabolic tumor volume on 18F-fluorodeoxyglucose positron emission tomography/ computed tomography in patients with diffuse large B-cell lymphoma receiving rituximab-containing chemotherapy

(2017) Chin-Chuan Chang et al.   Oncotarget

Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL

(2016) N. George Mikhaeel et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

From a pathologist's point of view: Histiocytic cells in Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma

(2015) Sylvia Hartmann   PATHOLOGY RESEARCH AND PRACTICE

Large B-Cell Lymphomas Poor in B Cells and Rich in PD-1+ T Cells Can Mimic T-Cell Lymphomas

(2014) Robert S. Ohgami et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial

(2014) D. Hoelzer et al.   BLOOD

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0

(2014) Ronald Boellaard et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma

(2014) Myriam Sasanelli et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Matched-Pair Analysis Comparing the Outcomes of T Cell/Histiocyte-Rich Large B Cell Lymphoma and Diffuse Large B Cell Lymphoma in Patients Treated with Rituximab-CHOP

(2013) Young Saing Kim et al.   ACTA HAEMATOLOGICA

An estimation of the number of cells in the human body

(2013) Eva Bianconi et al.   ANNALS OF HUMAN BIOLOGY

Does Functional Imaging Distinguish Nodular Lymphocyte-Predominant Hodgkin Lymphoma From T-Cell/Histiocyte-Rich Large B-Cell Lymphoma?

(2013) Nicholas A. Barber et al.   Clinical Lymphoma Myeloma & Leukemia

Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte Rich Large B Cell Lymphoma - Endpoints of a Spectrum of One Disease?

(2013) Sylvia Hartmann et al.   PLoS One

Interim FDG-PET in Hodgkin lymphoma: a compass for a safe navigation in clinical trials?

(2012) A. Gallamini et al.   BLOOD

Stromal Gene Signatures in Large-B-Cell Lymphomas

(2008) G. Lenz et al.   NEW ENGLAND JOURNAL OF MEDICINE